Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Lusomedicamenta Sociedade Tecnica Farmaceutica S.A
EIR
•Lusomedicamenta Sociedade Tecnica Farmaceutica S.A•September 27, 2019

Lusomedicamenta Sociedade Tecnica Farmaceutica S.A – FDA EIR, Sep 27, 2019

Record Details

An FDA Pre-Approval Inspection (PAI) and current Good Manufacturing Practices (cGMP) inspection of Lusomedicamenta Sociedade Tecnica Farmaceutica S.A. was conducted from September 23 to September 27, 2019. This inspection, requested by the Center for Veterinary Medicine (CVM), aimed to assess the company's readiness for commercial manufacturing, conformance to application, and data integrity for SurolanTM Otic Solution (NADA # 141298), alongside a comprehensive review of all six GMP systems. The regulatory framework included Compliance Programs 7368.001 for animal drugs in feeds and 7356.002 for drug manufacturing. The inspection concluded with the issuance of a five-item FDA-483, detailing significant observations. Key issues identified were an inadequate calibration procedure, deficiencies in raw material sample collection, failure to follow established process control procedures, unapproved changes to procedures not sanctioned by the client as per quality agreements, and restored electronic data not being reviewed according to schedule. In response, company management acknowledged these observations, committed to implementing necessary corrections, and pledged to submit a detailed written response within fifteen working days. The FDA's recommendation is to approve NADA 141298, with a classification of Voluntary Action Indicated (VAI), suggesting a re-inspection based on a scheduled workplan or sooner if deemed necessary.

Company
Lusomedicamenta Sociedade Tecnica Farmaceutica S.A
Inspection date
September 27, 2019
Product type
drugs
Office
Center for Veterinary Medicine
People
  • Yasamin Ameri (Compliance Officer)
  • Sandra A. Boyd (Drug National Expert)
View Company Profile

ID · 22f2ba89-6fb9-48f1-a8ba-219fd6234b56

Violation Codes1
21 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Lusomedicamenta Sociedade Tecnica Farmaceutica S.A
  • 483 - 2019-09-27September 27, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lusomedicamenta Sociedade Tecnica Farmaceutica S.A
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.